Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm

BackgroundLung cancer screening using low-dose computed tomography (LDCT) often leads to unnecessary biopsy because of the low specificity among patients with pulmonary nodules ≤10 mm. Circulating genetically abnormal cells (CACs) can be used to discriminate lung cancer from benign lung disease. To...

Full description

Bibliographic Details
Main Authors: Maosong Ye, Xiaoxuan Zheng, Xin Ye, Juncheng Zhang, Chuoji Huang, Zilong Liu, Meng Huang, Xianjun Fan, Yanci Chen, Botao Xiao, Jiayuan Sun, Chunxue Bai
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Oncology
Subjects:
lung cancer
pulmonary nodule
early detection
early diagnosis
circulating genetically abnormal cell (CAC)
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.638223/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.638223/full

Similar Items